Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,244 public trials 1,186 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer

NCT01700400

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Arizona Cancer Center Tuscon, Arizona, United States
  • University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
  • Providence Cancer Center Portland, Oregon, United States
  • Cancer Research And Biostatistics Clinical Trials Consortium Seattle, Washington, United States
View Trial Details
Completed

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

NCT00003313

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Huntsville Hospital System Huntsville, Alabama, United States
  • Comprehensive Cancer Institute of Huntsville Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
View all 264 locations
View Trial Details
Completed

Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

NCT01427946

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Colorado Denver Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine

NCT00228358

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +37 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer

NCT00799240

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Hutchinson Clinic, PA Hutchinson, Kansas, United States
  • Kansas University Cancer Center Kansas City, Kansas, United States
  • Stormont Vail Healthcare Topeka, Kansas, United States
  • VA Medical Center Kansas City, Missouri, United States
View Trial Details

Related conditions